Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection” by Jefferson M. Jones, Melissa M. Coughlin, Eduard Grebe, Michael P. Busch, Kristie E. N. Clarke

Get full text

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022. by Anna Bratcher, Jefferson M Jones, William A Meyer, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V Gundlapalli, Kristie E N Clarke

Get full text

Association of infection-induced antibody levels with risk of subsequent SARS–COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020–17 February 2021 by Jianrong Shi, M. Gayle Gabriel, Monica Epperson, Phil A. Chan, Jefferson M. Jones, Lyle R. Petersen, Melissa Briggs Hagen, Natalie J. Thornburg, Sharon Saydah, Claire M. Midgley

Get full text

Detection of SARS-CoV-2 Reinfections Using Nucleocapsid Antibody Boosting by Eduard Grebe, Daniel Chacreton, Mars Stone, Bryan R. Spencer, James Haynes, Akintunde Akinseye, Marion C. Lanteri, Valerie Green, Hasan Sulaeman, Roberta Bruhn, Vivian I. Avelino-Silva, Paul Contestable, Brad J. Biggerstaff, Melissa M. Coughlin, Brian Custer, Jefferson M. Jones, David Wright, Michael P. Busch

Get full text